Abstract
AbstractAbobotulinumtoxinA is a botulinum neurotoxin type A that blocks the release of acetylcholine from peripheral cholinergic nerve terminals and thereby induces flaccid paralysis. It is the second produced botulinum neurotoxin type A of its class and is currently approved for the use in spasticity, dystonia in adults, and correction of glabellar wrinkle lines in adults up to 65 years of age. Though these are the only US Food and Drug Administration (FDA) indications for its use, there are many off‐label uses for abobotulinumtoxinA such as various facial lines, hyperhidrosis, temporomandibular disease, and other neuromuscular conditions. This summary article reviews the history, development, unique properties, clinical indications, and safety profile of abobotulinumtoxinA.
Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
